Mrs. Rebecca L Pilgrim, NP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: Us 101, Soledad, CA 93960 Phone: 831-678-3951 |
Mrs. Nancy Louise Cain, NP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 32655 Camphora Rd, Soledad, CA 93960 Phone: 831-678-5354 Fax: 831-678-5438 |
Mr. Phillip Jones, NP-C Nurse Practitioner - Psych/Mental Health Medicare: Accepting Medicare Assignments Practice Location: 359 Gabilan Dr, Soledad, CA 93960 Phone: 831-769-8740 |
Mr. Randulf Villanueva Erguiza, MS, NP, FNP-BC, NP-C Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 31625 Highway 101 S, Soledad, CA 93960 Phone: 831-678-5500 |
Christine Margaret Michaels Benson, FNP-C Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 600 Main St, Soledad, CA 93960 Phone: 831-594-7680 Fax: 831-678-0776 |
News Archive
In a recent study released on the bioRxiv* preprint server, the researchers suggest that an aberrant inflammatory reaction associated with COVID-19 could be a result of escape from direct sensing by toll-like receptors (TLRs). Moreover, the researchers indicate that this phenomenon might underlie the lack of efficient immunity to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) early during infection.
National Institutes of Health scientists studying SARS-CoV-2, the virus that causes COVID-19, have defined in Syrian hamsters how different routes of virus exposure are linked to disease severity.
PTC Therapeutics, Inc. today announced that following its request for re-examination, the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion regarding the company's application for a conditional marketing authorization of Translarna (ataluren) for the treatment of nonsense mutation Duchenne muscular dystrophy (nmDMD) in ambulatory patients aged five years and older.
Jamieson Laboratories, Canada's largest manufacturer of advanced natural-health products, announced the release of FluShield™, a clinically proven flu-fighting formula that is made with a patented, next-generation echinacea extract known as LPx3.
According to the World Health Organization (WHO), one-third of the world's population is currently infected with tuberculosis bacteria. The bacteria is incredibly resistant to treatment, and despite its prevalence, very little is known about why it is so stress tolerant. But, researchers at the University of Pittsburgh have been developing a new way of culturing tuberculosis bacteria, which could lead to new insights and treatments.
› Verified 4 days ago